Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge

被引:35
作者
Cho, Joo-Youn [1 ]
Matsubara, Tsutomu [1 ]
Kang, Dong Wook [2 ]
Ahn, Sung-Hoon [1 ]
Krausz, Kristopher W. [1 ]
Idle, Jeffrey R. [3 ]
Luecke, Hans [2 ]
Gonzalez, Frank J. [1 ]
机构
[1] NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NIDDKD, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[3] Charles Univ Prague, Inst Pharmacol, Fac Med 1, Prague, Czech Republic
关键词
adaptive response; cholic acid; cortico-sterone; Cyp3a11; farnesoid X receptor; lithocholic acid; metabolomics; p-cresol; FARNESOID-X-RECEPTOR; LITHOCHOLIC ACID; NUCLEAR RECEPTOR; LIVER TOXICITY; DETOXIFICATION; ALPHA; CORTICOSTERONE; IDENTIFICATION; ELIMINATION; OBSTRUCTION;
D O I
10.1194/jlr.M002923
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Farnesoid X receptor (FXR) is a nuclear receptor that regulates genes involved in synthesis, metabolism, and transport of bile acids and thus plays a major role in maintaining bile acid homeostasis. In this study, metabolomic responses were investigated in urine of wild-type and Fxr-null mice fed cholic acid, an FXR ligand, using ultra-performance liquid chromatography (UPLC) coupled with electrospray time-of-flight mass spectrometry (TOFMS). Multivariate data analysis between wild-type and Fxr-null mice on a cholic acid diet revealed that the most increased ions were metabolites of p-cresol (4-methylphenol), corticosterone, and cholic acid in Fxr-null mice. The structural identities of the above metabolites were confirmed by chemical synthesis and by comparing retention time (RT) and/or tandem mass fragmentation patterns of the urinary metabolites with the authentic standards. Tauro-3 alpha,6,7 alpha,12 alpha-tetrol (3 alpha,6,7 alpha,12 alpha-tetrahydroxy-5 beta-cholestan-26-oyltaurine), one of the most increased metabolites in Fxr-null mice on a CA diet, is a marker for efficient hydroxylation of toxic bile acids possibly through induction of Cyp3a11. A cholestatic model induced by lithocholic acid revealed that enhanced expression of Cyp3a11 is the major defense mechanism to detoxify cholestatic bile acids in Fxr-null mice. These results will be useful for identification of biomarkers for cholestasis and for determination of adaptive molecular mechanisms in cholestasis.-Cho, J. Y., T. Matsubara, D. W. Kang, S. H. Ahn, K. W. Krausz, J. R. Idle, H. Luecke, and F. J. Gonzalez. Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge. J. Lipid Res. 2010. 51: 1063-1074.
引用
收藏
页码:1063 / 1074
页数:12
相关论文
共 36 条
[1]   Novel pathways of bile acid metabolism involving CYP3A4 [J].
Bodin, K ;
Lindbom, U ;
Diczfalusy, U .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2005, 1687 (1-3) :84-93
[2]   LC-MS-based metabolomics in drug metabolism [J].
Chen, Chi ;
Gonzalez, Frank J. ;
Idle, Jeffrey R. .
DRUG METABOLISM REVIEWS, 2007, 39 (2-3) :581-597
[3]   Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation [J].
Cho, Joo-Youn ;
Kang, Dong Wook ;
Ma, Xiaochao ;
Ahn, Sung-Hoon ;
Krausz, Kristopher W. ;
Luecke, Hans ;
Idle, Jeffrey R. ;
Gonzalez, Frank J. .
JOURNAL OF LIPID RESEARCH, 2009, 50 (05) :924-937
[4]  
DAYAL B, 1995, SYNLETT, P861
[5]   Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice [J].
Fickert, P ;
Fuchsbichler, A ;
Marschall, HU ;
Wagner, M ;
Zollner, G ;
Krause, R ;
Zatloukal, K ;
Jaeschke, H ;
Denk, H ;
Trauner, M .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (02) :410-422
[6]   Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity [J].
Guo, GL ;
Lambert, G ;
Negishi, M ;
Ward, JM ;
Brewer, HB ;
Kliewer, SA ;
Gonzalez, FJ ;
Sinal, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45062-45071
[7]  
HAN A, 1983, J BIOL CHEM, V258, P3703
[8]   Detoxification of lithocholic acid, a toxic bile acid: Relevance to drug hepatotoxicity [J].
Hofmann, AF .
DRUG METABOLISM REVIEWS, 2004, 36 (3-4) :703-722
[9]   Metabolomics [J].
Idle, Jeffrey R. ;
Gonzalez, Frank J. .
CELL METABOLISM, 2007, 6 (05) :348-351
[10]  
IIDA T, 1990, STEROIDS, V55, P530